Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis

Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis

IntroductionThe use of immune checkpoint inhibitors (ICIs) as a front-line treatment for metastatic renal cell carcinoma (RCC) has significantly improved patient’ outcome. However, little is known about the efficacy or lack thereof of immunotherapy after prior use of anti-PD1/PD-L1 or/and anti-CTLA...

Full description

Bibliographic Details
Main Authors: Maria Papathanassiou, Ioannis Tamposis, Kalliopi K. Exarchou-Kouveli, Panagiota I. Kontou, Anna Tzortzi de Paz, Lampros Mitrakas, Maria Samara, Pantelis G. Bagos, Vassilios Tzortzis, Panagiotis J. Vlachostergios
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
immune checkpoint inhibitor
rechallenge
salvage
second-line
VEGF TKI
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.996553/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.996553/full

Similar Items